Video 22 February 2013

IFPMA technical briefing on biopharmaceutical innovation: making natural product research work


Overview of contents and objectives of the Technical Briefing
Andrew Jenner — Director of Innovation, Intellectual Property and Trade (IFPMA)


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit

Learn more

Media Contact

Elliot Dunster